Johnson & Johnson (JNJ) Q2 2026 (USD): Adj. EPS 2.90 (exp. 2.86), Revenue 25.3bln (exp. 25.02bln); lifts 2026 outlook
#UNITED STATES#USD#EUR#JAPAN#JPY#UNITED KINGDOM#GBP#EUROPE#JOHNSON & JOHNSON#JNJ.US#IMPORTANT#FOREX#EQUITIES#METALS#EU SESSION#PHARMACEUTICALS#METALS & MINING#PHARMACEUTICALS (GROUP)#PHARMACEUTICALS, BIOTECHNOLOGY & LIFE SCIENCES#S&P 500 INDEX#JNJ#DXY#US EQUITIES